OUR PRODUCTS

MOBILE APPS

GENERAL INFO

PTGX

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Protagonist Therapeutics (PTGX) Earnings Date & Reports

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

PTGX is expected to report earnings to rise 10.82% to -60 cents per share on November 05

Protagonist Therapeutics PTGX Stock Earnings Reports

Q3'25

Est.

$-0.61

Q2'25

Beat

by $0.03

Q1'25

Missed

by $0.12

Q4'24

Beat

by $1.79

Q3'24

Beat

by $0.04

The last earnings report on August 06 showed earnings per share of -55 cents, beating the estimate of -57 cents. With 49.92K shares outstanding, the current market capitalization sits at 3.18B.

View a ticker or compare two or three

Compare

Search For Dips Search For Dips

Annualized Return+29%

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

PTGX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For PTGX
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. PTGX showed earnings on August 06, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a developer of disulfide-rich peptides

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

7707 Gateway Boulevard

Phone

+1 510 474-0170

Employees

112

Web

https://www.protagonist-inc.com